(Press-News.org) Research led by UCL, in partnership with the MRC Laboratory of Molecular Biology (MRC LMB) and AstraZeneca, has identified a new compound that can stimulate nerve regeneration after injury, as well as protect cardiac tissue from the sort of damage seen in heart attack.
The study, published in Nature, identified a chemical compound, named ‘1938’, that activates the PI3K signalling pathway, and is involved in cell growth. Results from this early research showed the compound increased neuron growth in nerve cells, and in animal models, it reduced heart tissue damage after major trauma and regenerated lost motor function in a model of nerve injury.
Though further research is needed to translate these findings into the clinic, 1938 is one of just a few compounds in development that can promote nerve regeneration, for which there are currently no approved medicines.
Phosphoinositide 3-kinase (PI3K) is a type of enzyme that helps to control cell growth. It is active in various situations, such as initiating wound healing, but its functions can also be hijacked by cancer cells to allow them to proliferate. As a result, cancer drugs have been developed that inhibit PI3K to restrict tumour growth. But the clinical potential of activating the PI3K pathway remains underexplored.
Dr Roger Williams, a senior author of the study from the MRC Laboratory of Molecular Biology, said: “Kinases are ‘molecular machines’ that are key to controlling the activities of our cells, and they are targets for a wide range of drugs. Our aim was to find activators of one of these molecular machines, with the goal of making the machine work better. We found that we can directly activate a kinase with a small molecule to achieve therapeutic benefits in protecting hearts from injury and stimulating neural regeneration in animal studies.”
In this study, researchers from UCL and MRC LMB worked with researchers from AstraZeneca to screen thousands of molecules from its chemical compound library to create one that could activate the PI3K signalling pathway. They found that the compound named 1938 was able to activate PI3K reliably and its biological effect were assessed through experiments on cardiac tissue and nerve cells.
Researchers at UCL’s Hatter Cardiovascular Institute found that administering 1938 during the first 15 minutes of blood flow restoration following a heart attack provided substantial tissue protection in a preclinical model. Ordinarily, areas of dead tissue form when blood flow is restored that can lead to heart problems later in life.
When 1938 was added to lab-grown nerve cells, neuron growth was significantly increased. A rat model with a sciatic nerve injury was also tested, with delivery of 1938 to the injured nerve resulting in increased recovery in the hind leg muscle, indicative of nerve regeneration.
Professor James Phillips (UCL School of Pharmacy), a senior author of the study, said: “There are currently no approved medicines to regenerate nerves, which can be damaged as a result of injury or disease, so there’s a huge unmet need. Our results show that there’s potential for drugs that activate PI3K to accelerate nerve regeneration and, crucially, localised delivery methods could avoid issues with off-target effects that have seen other compounds fail.”
Given the positive findings, the group is now working to develop new therapies for peripheral nerve damage, such as those sustained in serious hand and arm injuries. They are also exploring whether PI3K activators could be used to help treat damage in the central nervous system, for example due to spinal cord injury, stroke or neurodegenerative disease.
Professor Bart Vanhaesebroeck (UCL Cancer Institute), a senior author of the study, said: “This is a prime example of interdisciplinary research, in which people with expertise ranging from basic science, drug development and clinical studies join forces around an innovative idea, whilst also crossing boundaries between academia and industry. 'Blue sky’ research of this kind is difficult to get funding for in a world of increasing specialisation, but hopefully this project can provide something of a model for future ambitious research.”
An important factor in the overall success of the study was UCL’s Drug Discovery Group from the Translational Research Office supporting the drug discovery programme and participation in AstraZeneca’s ‘Open Innovation’ programme, which sees the company collaborating with academics that have innovative ideas to advance drug discovery and development.
Mike Snowden, Senior Vice President, Discovery Sciences at AstraZeneca, said: “Our Open Innovation programme aims to create an open research environment that connects our expertise and technologies with the innovative and ambitious research ideas of collaborators like UCL and MRC LMB, with the aim of uncovering novel biology and biological mechanisms.”
This research was funded by Wellcome, UKRI, MRC, NIHR UCLH Biomedical Research Centre, European Union Horizon 2020, the British Heart Foundation, the Rosetrees Trust and CRUK.
END
New chemical compound demonstrates potential in nerve regeneration
2023-05-24
ELSE PRESS RELEASES FROM THIS DATE:
New research finds dramatic increase in illegal ketamine seized by authorities, sparking concern about potential dangers of rising recreational use
2023-05-24
A new analysis led by NYU Grossman School of Medicine and the National Drug Early Warning System (NDEWS) at the University of Florida found a 349 percent rise in seizures of illicit ketamine by drug enforcement throughout the United States from 2017 through 2022.
The study findings suggest that rising use of ketamine, a short-acting dissociative anesthetic commonly prescribed off-label to treat chronic pain and depression, can increase the likelihood that people who use recreationally or who use inadvertently may encounter an adulterated and potentially harmful version of the drug. The study publishes online May 24 in JAMA Psychiatry.
“This ...
COVID-19 and risk for mental disorders among adults in Denmark
2023-05-24
About The Study: In this Danish nationwide cohort study, overall risk of new-onset mental disorders in SARS-CoV-2–positive individuals did not exceed the risk among individuals with negative test results (except for those age 70 and older). However, when hospitalized, patients with COVID-19 had markedly increased risk compared with the general population, but comparable to risk among patients hospitalized for non–COVID-19 infections. Future studies should include even longer follow-up time and preferentially ...
Association of community vulnerability and state gun laws with firearm deaths in children and adolescents
2023-05-24
About The Study: In this study including 5,813 youths ages 10 to 19 who died of an assault-related firearm injury, socially vulnerable communities in the U.S. experienced a disproportionate number of assault-related firearm deaths among youths. Although stricter gun laws were associated with lower death rates in all communities, these gun laws did not equalize the consequences on a relative scale, and disadvantaged communities remained disproportionately impacted. While legislation is necessary, it may not be sufficient to solve the problem of assault-related firearm deaths among children and adolescents.
Authors: Deepika Nehra, M.D., of the University ...
Cannabis use disorder and subsequent risk of psychotic and nonpsychotic unipolar depression and bipolar disorder
2023-05-24
About The Study: This study of 6.6 million individuals in Demark found that cannabis use disorder was associated with an increased risk of psychotic and nonpsychotic bipolar disorder and unipolar depression. These findings may inform policies regarding the legal status and control of cannabis use.
Authors: Oskar Hougaard Jefsen, M.D., of Aarhus University Hospital–Psychiatry in Aarhus, Denmark, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(10.1001/jamapsychiatry.2023.1256)
Editor’s ...
Quantum matter breakthrough: Tuning density waves
2023-05-24
“Cold atomic gases were well known in the past for the ability to ‘program’ the interactions between atoms,” says Professor Jean-Philippe Brantut at EPFL. “Our experiment doubles this ability!” Working with the group of Professor Helmut Ritsch at the University of Innsbruck, they have made a breakthrough that can impact not only quantum research but quantum-based technologies in the future.
Density waves
Scientists have long been interested in understanding how materials self-organize into complex structures, such as crystals. In the often-arcane world of quantum physics, ...
Fewer suicides among boys in regions with more bipolar diagnoses
2023-05-24
Bipolar disorder underlies roughly five percent of all suicides among young people. Previous studies also show that there is often a long delay between the onset of bipolarism and its correct diagnosis and treatment. Researchers at Karolinska Institutet now show that fewer boys commit suicide in Swedish regions where bipolar diagnoses are more common. The study, which is published in JAMA Psychiatry, could contribute to more proactive care for reducing the number of suicides.
“Bipolar disorder is often more distressing for people who develop it early in life and is one of the psychiatric disorders most associated with suicide risk,” says ...
Scientists find first evidence for new superconducting state in Ising superconductor
2023-05-24
In a ground-breaking experiment, scientists from the University of Groningen, together with colleagues from the Dutch universities of Nijmegen and Twente and the Harbin Institute of Technology (China), have discovered the existence of a superconductive state that was first predicted in 2017. They present evidence for a special variant of the FFLO superconductive state on 24 May in the journal Nature. This discovery could have significant applications, particularly in the field of superconducting electronics.
The lead author of the paper is Professor Justin Ye, who heads the Device Physics of Complex Materials group at the University of Groningen. Ye and his team have ...
Where do our limbs come from?
2023-05-24
For Immediate Release
Contact: Mark Couch, 303-724-5377, mark.couch@cuanschutz.edu
Where Do Our Limbs Come From?
AURORA, Colo. (May 24, 2023) – An international collaboration that includes scientists from the University of Colorado School of Medicine has uncovered new clues about the origin of paired appendages – a major evolutionary step that remains unresolved and highly debated.
The researchers describe their study in an article published today in the journal Nature.
“This has become ...
In resistance training, focusing on load or number of repetitions leads to same muscle growth
2023-05-24
Which kind of resistance training promotes more muscle growth: low load with many repetitions or high load with fewer repetitions? According to a study conducted at the State University of Campinas (UNICAMP) in São Paulo state, Brazil, it makes no difference.
The study lasted eight weeks and involved 18 volunteers in two different training protocols. One group performed high-load (HL) exercises with fewer repetitions, while the other did low-load (LL) exercises with more repetitions. Muscle mass was measured in the first and last exercise sessions. A comparison of the two groups did not show any difference in muscle growth or metabolic stress, measured in an ...
Why do some long Covid patients continue to have difficulty exercising?
2023-05-24
While some patients recover from the effects of SARS-CoV-2 infection, others have experienced the aftereffects of COVID-19 long after the initial infection. One of these long COVID symptoms is reduced exercise capacity. But questions remain about the mechanisms underlying why some COVID patients continue to experience diminished exercise capacity while others recover without this condition.
In a study recently published in the Journal of Infectious Diseases, a team of researchers from UC San Francisco found that lower than expected exercise capacity was common ...